S&P Global Ratings, Moody’s Corp. (MCO) and Fitch Ratings Inc. warn that mounting public pressure to cut medical costs has recently threatened the industry’s credit amid a renewed political debate on drug pricing and national health insurance.
S&P Global Ratings, Moody’s Corp. (MCO) and Fitch Ratings Inc. warn that mounting public pressure to cut medical costs has recently threatened the industry’s credit amid a renewed political debate on drug pricing and national health insurance.